569 related articles for article (PubMed ID: 26373570)
21. The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study.
Boaz M; Lisy L; Zandman-Goddard G; Wainstein J
Diabet Med; 2009 Jul; 26(7):708-13. PubMed ID: 19573120
[TBL] [Abstract][Full Text] [Related]
22. Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies.
Wang Y; Liu X; Yan P; Tang J; Chen T; Sun Y; Zhou W; Bi Y; Zhang ZJ
Eur J Cancer Prev; 2020 Jan; 29(1):42-52. PubMed ID: 30950925
[TBL] [Abstract][Full Text] [Related]
23. Statins and prostate cancer prevention: where we are now, and future directions.
Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
[TBL] [Abstract][Full Text] [Related]
24. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
25. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study.
Marrone MT; Mondul AM; Prizment AE; Couper D; Barber JR; Chappidi MR; Joshu CE; Platz EA
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34738072
[TBL] [Abstract][Full Text] [Related]
26. Recent developments in esophageal adenocarcinoma.
Lagergren J; Lagergren P
CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
[TBL] [Abstract][Full Text] [Related]
27. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies.
Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865
[TBL] [Abstract][Full Text] [Related]
28. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
29. Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients.
Lehman DM; Lorenzo C; Hernandez J; Wang CP
Diabetes Care; 2012 May; 35(5):1002-7. PubMed ID: 22456867
[TBL] [Abstract][Full Text] [Related]
30. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
[TBL] [Abstract][Full Text] [Related]
31. The Epidemiology of Prostate Cancer.
Pernar CH; Ebot EM; Wilson KM; Mucci LA
Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311132
[TBL] [Abstract][Full Text] [Related]
32. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence.
Terry PD; Rohan TE; Wolk A
Am J Clin Nutr; 2003 Mar; 77(3):532-43. PubMed ID: 12600840
[TBL] [Abstract][Full Text] [Related]
33. Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
Gales L; Forsea L; Mitrea D; Stefanica I; Stanculescu I; Mitrica R; Georgescu M; Trifanescu O; Anghel R; Serbanescu L
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143915
[TBL] [Abstract][Full Text] [Related]
34. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
Sehdev A; O'Neil BH
Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
[TBL] [Abstract][Full Text] [Related]
35. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
36. Obesity and Diabetes.
Aras M; Tchang BG; Pape J
Nurs Clin North Am; 2021 Dec; 56(4):527-541. PubMed ID: 34749892
[TBL] [Abstract][Full Text] [Related]
37. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
38. The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.
Zhang Y; Chen H; Chen S; Li Z; Chen J; Li W
Oncoimmunology; 2021; 10(1):1957605. PubMed ID: 34377596
[TBL] [Abstract][Full Text] [Related]
39. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival.
Currie CJ; Poole CD; Jenkins-Jones S; Gale EA; Johnson JA; Morgan CL
Diabetes Care; 2012 Feb; 35(2):299-304. PubMed ID: 22266734
[TBL] [Abstract][Full Text] [Related]
40. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III.
Moyad MA
Curr Urol Rep; 2020 May; 21(5):22. PubMed ID: 32367257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
